Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators - Topol, EJ; Califf, RM; Weisman, HF; Ellis, SG; Tcheng, JE; Worley, S; Ivanhoe, R; George, BS; Fintel, D; Weston, M; Sigmon, K; Anderson, KM; Lee, KL; Willerson, JT (Lancet, 1994)